Biotechnology | Disease | FDA | Therapeutics
US FDA approves Vera’s kidney disease drug
On Jul. 7, 2026, the U.S. Food and Drug Administration has approved Vera Therapeutics’ drug to treat patients…
-
-
Novartis to acquire Myricx Bio for $1.5 Billion
On Jul. 6, 2026, Novartis announced it has reached an agreement to acquire Myricx Bio for up to…
-
Immunotherapy shows promise in treating deadly brain tumours
On Jul. 1, 2026, a study led by a researcher based at King’s College London and McMaster University…
-
World’s first synthetic cell with a complete life cycle could revolutionize biological engineering
On Jul. 1, 2026, Associate Professors Kate Adamala and Aaron Engelhart and their teams at the College of…
-
Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery Worth $600 million
On Jul. 1, 2026, Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, announced a strategic…
-
Professor Chih-Ying Su Leaves U.S. to join Shenzhen Medical Academy of Research and Translation
On Jul. 1, 2026, Professor Chih-Ying Su, previously Professor and Vice Chair of the Department of Neurobiology at…
-
Artificial Intelligence | Biotechnology | CRISPR | CRO | Diagnostics | Genomics | Imaging | Infectious Disease | Medicine | Nanotechnology | Neurology | Oncology | Organoids | Pharmaceutical | Robotics | Stem Cell | Therapeutics | Vaccine | Veterinary | Women's Health
Anthropic debuts AI-driven pharma R&D tool, Claude Science
On Jul. 1, 2026, tech giant Anthropic announced it has extended its foray into the life sciences space…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | NIH | Therapeutics
HHS Secretary Signs COVID-19 Emergency Use Authorization Declaration Terminations
On Jun. 30, 2026, The U.S. Department of Health and Human Services (HHS) announced that Secretary Robert F….
-
EU Approves first tumour agnostic HER2-directed therapy for Breast Cancer
On Jun. 29, 2026, AstraZeneca and Daiichi Sankyo’s announced that Enhertu (trastuzumab deruxtecan) had been approved in the…
-
Hanyang University Researchers Develop AI-designed Shape-Shifting Microneedles for Diabetic Wound Healing
On Jun. 26, 2026, Chronic diabetic wounds heal slowly and are highly vulnerable to infection. Researchers report developing…
-
Self-propelled actin filaments: Novel structures driving spontaneous cell morphogenesis
On Jun. 25, 2026, researchers from the Nara Institute of Science and Technology report that every time a…
-
Dementia Will Cost the U.S. $818 Billion in 2026, USC-Led Study Finds
On Jun. 24, 2026, A University of Southern California (USC)-led study finds Alzheimer’s disease and related dementias will…
-
Antares Therapeutics signs potential $1.9 billion cancer drug deal with Novartis
On Jun. 24, 2026, Antares Therapeutics announce it has entered a collaboration with Novartis that could be worth…
-
U.S. FDA Approves Trodelvy® for First-Line Treatment of Metastatic Triple-Negative Breast Cancer
On Jun. 24, 2026, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has approved Trodelvy®…
-
Nanoparticles sneak antibodies into cells to inhibit cancer, inflammation
On Jun. 23. 2026, scientists at Cornell University announce discovering a delivery system that uses lipid nanoparticles to…
-
Biotechnology | CDC | Diagnostics | Infectious Disease | NIH | Therapeutics | Vaccine | WHO
US provides Ebola treatment for outbreak in Congo, bringing trials closer
On Jun. 23, 2026, the U.S. has provided doses of an experimental antibody drug from Mapp Biopharmaceutical for…
-
Manning Family Children’s makes history as Louisiana’s first Sickle Cell Disease gene therapy marking his functional cure
On Jun. 22, 2026, Louisiana’s first Sickle Cell Disease gene therapy patient is now set to pursue his…
-
USC Stem Cell-led team creates a renewable cell source for cancer immunotherapy and beyond
On Jun. 19, 2026, University of Southern California (USC) scientists report in a paper published in Cell, a…
-
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera for $1 Billion
On Jun. 17, 2026, Biogen and RayThera, a private biotechnology company focused on discovering and developing small molecule…
-
FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose
On Jun. 16, 2026, the U.S. Food and Drug Administration (FDA) approved another over-the-counter (OTC) intranasal naloxone product,…
-
USDA Invests in Projects to Strengthen New World Screwworm Preparedness and Response
On Jun. 16, 2026, the U.S. Department of Agriculture (USDA) is announcing funding for 40 breakthrough projects to…
-
Biotechnology | Disease | NIH | Therapeutics
University of Oklahoma Receives $11.5 Million NIH Award to Establish Statewide Immunoengineering Research Center
On Jun. 11, 2026, the University of Oklahoma (OU) announced it had received an $11.5 million award from…
-
FDA Issues EUA for Generic Over-the-Counter Drug to Treat New World Screwworm in Dogs and Cats
On Jun. 11, 2026, The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) for generic…
-
USDA Responds to New World Screwworm; New Case Confirmed in La Salle County, Texas
On Jun. 9, 2026, The U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS), alongside…
-
First-in-the-world gene therapy delivers missing gene directly to infant’s brain, marking historic milestone in precision medicine
On Jun. 8, 2026, an eight-month-old infant with a severe genetic epilepsy has become the first patient in…
-
Artificial Intelligence | Biotechnology | Clinical Research | Genomics | Pharmaceutical | Therapeutics
Google DeepMind, Google.org and Sanger Institute to launch new AI consortium for genomics
On Jun. 8, 2026, the Wellcome Sanger Institute, Google.org, and Google DeepMind announced they are partnering up to…
-
Incyte to Acquire Vega Therapeutics, Subsidiary of Star Therapeutics, for $1.25 billion, Expanding its Hematology Portfolio into Bleeding Disorders
On Jun. 8, 2026, Incyte announced it has entered into a definitive agreement to acquire Vega Therapeutics, a wholly owned…
-
Roche announces global collaboration with Nurix Therapeutics worth up to $2.3 billion
On Jun. 7, 2026, Roche announced that it has entered into an exclusive licensing and collaboration agreement with…
-
Bioprinting Cartilage, Producing Stem Cells Fill ISS Research Schedule
On Jun. 4, 2026, 3D bioprinting and stem cell research were the main research topics aboard the International…
-
Lilly gains license for Ascidian’s gene-editing tech to develop kidney disease drugs worth up to $1.9 billion
On Jun. 3, 2026, Ascidian Therapeutics said it has signed a licensing deal for its gene-editing technology with…
